Immunotherapy of cancer with allogeneic lymphocytes
作者： Shimon Slavin
DOI:
关键词: In vitro 、 Immunotherapy 、 Disease 、 Stem cell 、 Immunology 、 Allogeneic Lymphocyte 、 Cancer 、 Haematopoiesis 、 Medicine 、 In vivo
摘要: Methods have been discovered for treating residual disease following removal of most or a substantial fraction malignant cells from cancer patient. An autologous stem cell transplant is performed on the Following partial hematopoiesis recovery, patient infused with allogeneic peripheral blood lymphocytes, either alone in combination vivo vitro T-cell activation. The lymphocytes engender and anti-malignant response.
lens.org 参考文章(23)
Drobyski Wr, Johnson Bd, Truitt Rl, Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease Bone Marrow Transplantation. ,vol. 11, pp. 329- 336 ,(1993)
A Ackerstein, E Kedar, S Slavin, Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders. Blood. ,vol. 78, pp. 1212- 1215 ,(1991) , 10.1182/BLOOD.V78.5.1212.1212
RL Truitt, AA Atasoylu, Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation Blood. ,vol. 77, pp. 2515- 2523 ,(1991) , 10.1182/BLOOD.V77.11.2515.2515
JJ Mule, Suyu Shu, SA Rosenberg, None, The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo. Journal of Immunology. ,vol. 135, pp. 646- 652 ,(1985)
Steven A. Rosenbert, Adoptive immunotherapy as a treatment modality in humans ,(1986)
M. Sykes, M. L. Romick, D. H. Sachs, Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 5633- 5637 ,(1990) , 10.1073/PNAS.87.15.5633
Shimon Slavin, Aliza Ackerstein, Urania Vourka-Karussis, Arnon Nagler, Reuven Or, Elizabeth Naparstek, Lola Weiss, Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation. Baillière's clinical haematology. ,vol. 4, pp. 715- 725 ,(1991) , 10.1016/S0950-3536(09)90009-9
J. Mule, S Shu, S. Schwarz, S. Rosenberg, Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science. ,vol. 225, pp. 1487- 1489 ,(1984) , 10.1126/SCIENCE.6332379
Shimon Slavin, Arnon Nagler, New developments in bone marrow transplantation. Current Opinion in Oncology. ,vol. 3, pp. 254- 271 ,(1991) , 10.1097/00001622-199104000-00005